DDAH1 and depressive disorder: Finally, paroxetine treatment normalized DDAH1 expression in the hypothalamus and amygdala, reduced oxidative stress, and alleviated depressive-like behaviors, underscoring its potential in treating conditions that involve both depression and oxidative stress (162).